ISB News

The Other Malaria: Finding New Targets for a Vaccine Against Plasmodium vivax

Warhol style Plasmodium

A new report in PLOS Neglected Tropical Diseases describes the results of an international collaboration led by researchers at ISB and Seattle’s Center for Infectious Disease Research (CIDResearch). We used mass spectrometry-based proteomics to identify nearly 2,000 proteins present in Plasmodium vivax parasites, one of the Plasmodium species that cause the disease malaria in humans. The work was done on parasites dissected from mosquito salivary glands, parasites that were in the form that is transmitted from mosquitoes to humans. Because parasite proteins can potentially be recognized by the body’s immune system, the proteins we have identified are promising targets for new vaccines against malaria.

Read More

Recent Articles

  • Valerie Logan Luncheon emcee Heather Logan

    ‘Innovation to Impact:’ 8th Annual Valerie Logan Luncheon Shines Light on ISB Education

    The 8th Annual Valerie Logan Luncheon celebrated ISB Education’s mission of engaging entire school systems — from principals and administrators to teachers and students — to ensure all students are STEM literate. Nearly 100 people attended the event at ISB, and generously gave more than $100,000 for ISB Education.

  • Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease

    ISB researchers and their collaborators are using systems biology approaches to learn how the malaria parasite is able to transfer to humans via the bite of an infected mosquito. The information they have uncovered may help identify new ways to prevent people from contracting the deadly disease.

  • ISB Unveils New Brand Ahead of 20th Anniversary

    We created a new brand identity — including logo and tag line — to reflect ISB’s evolution since our inception in 2000, and ahead of our 20th anniversary. ISB is proud to be a part of the vibrant research community in Seattle, and is committed to translational and collaborative science.